Literature DB >> 8030279

Enterotropic strains of mouse coronavirus differ in their use of murine carcinoembryonic antigen-related glycoprotein receptors.

S R Compton1.   

Abstract

Enterotropic mouse hepatitis virus strains (MHV-RI and MHV-Y) replicate in the intestine and rarely disseminate to other tissues, unlike respiratory MHV strains. Murine carcinoembryonic antigen-related glycoproteins (MHVR and mmCGM2) are expressed in many murine tissues and serve as receptors for respiratory MHV strains. To assess the role of receptors in the limited tissue tropism of enterotropic MHV strains, the permissiveness of MHVR- and mmCGM2-expressing cell lines and peritoneal exudate cells from BALB/c and SJL mice for MHV-RI and MHV-Y replication was determined. MHVR-transfected BHK cells were susceptible to infection with both MHV-RI and MHV-Y. Additionally, the anti-MHVR monoclonal antibody CC1 blocked MHV-RI and MHV-Y infection. mmCGM2-transfected BHK cells were susceptible to infection with MHV-Y, but not MHV-RI. Peritoneal exudate cells from BALB/c mice were susceptible to infection with MHV-Y and MHV-RI, whereas peritoneal exudate cells from SJL mice were susceptible to infection with MHV-Y but not MHV-RI. These results indicate that MHV-RI probably uses a different receptor than other MHV strains to infect SJL mice and that receptors are probably not the primary determinant of the limited tissue tropism of enterotropic MHV strains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030279      PMCID: PMC7131022          DOI: 10.1006/viro.1994.1475

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8.

Authors:  Bruce D Zelus; Jeanne H Schickli; Dianna M Blau; Susan R Weiss; Kathryn V Holmes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection.

Authors:  D M Blau; C Turbide; M Tremblay; M Olson; S Létourneau; E Michaliszyn; S Jothy; K V Holmes; N Beauchemin
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence.

Authors:  W Chen; R S Baric
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

Authors:  B D Zelus; D R Wessner; R K Williams; M N Pensiero; F T Phibbs; M deSouza; G S Dveksler; K V Holmes
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells.

Authors:  P V Rao; S Kumari; T M Gallagher
Journal:  Virology       Date:  1997-03-17       Impact factor: 3.616

Review 7.  The molecular biology of coronaviruses.

Authors:  M M Lai; D Cavanagh
Journal:  Adv Virus Res       Date:  1997       Impact factor: 9.937

8.  The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain.

Authors:  Cornelis A M de Haan; Marèl de Wit; Lili Kuo; Cynthia Montalto-Morrison; Bart L Haagmans; Susan R Weiss; Paul S Masters; Peter J M Rottier
Journal:  Virology       Date:  2003-08-01       Impact factor: 3.616

9.  Molecular characterization of the S proteins of two enterotropic murine coronavirus strains.

Authors:  S Kunita; L Zhang; F R Homberger; S R Compton
Journal:  Virus Res       Date:  1995-03       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.